Alphatec Holdings Inc. (ATEC)
Alphatec Holdings, Inc. (ATEC) Q2 2026 Earnings Call Transcript
Alphatec Holdings, Inc. (ATEC) Q2 2026 Earnings Call Transcript
Alphatec (ATEC) Q2 Earnings Lag Estimates
Alphatec (ATEC) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.02 per share a year ago.
Alphatec Q2 Earnings Call Highlights
Alphatec NASDAQ: ATEC reported second-quarter 2026 revenue of $214 million, up 15% from a year earlier, as growth in surgical procedures and surgeon adoption supported higher profitability and positive free cash flow.
Alphatec - Slower Growth Seems Priced In Here
Alphatec Holdings shares have dropped two-thirds YTD, now trading at just over 2x sales, reflecting sharply decelerating growth and persistent losses. Q1 2026 revenue grew only 14% to $192.1M, prompting a slight full-year sales guidance cut; adjusted EBITDA margins improved but remain heavily adjusted. Despite a $466M net debt load and ongoing dilution, Alphatec demonstrates real operating leverage, with manageable losses and a credible path toward profitability.
Alphatec Holdings, Inc. (ATEC) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
Alphatec Holdings, Inc. (ATEC) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
Alphatec Holdings, Inc. (ATEC) Q1 2026 Earnings Call Transcript
Alphatec Holdings, Inc. (ATEC) Q1 2026 Earnings Call Transcript
Alphatec (ATEC) Reports Break-Even Earnings for Q1
Alphatec (ATEC) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.23 per share a year ago.
Implied Volatility Surging for Alphatec Stock Options
Investors need to pay close attention to ATEC stock based on the movements in the options market lately.
Alphatec (NASDAQ:ATEC) and Sysmex (OTCMKTS:SSMXY) Critical Survey
Alphatec (NASDAQ: ATEC - Get Free Report) and Sysmex (OTCMKTS:SSMXY - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, valuation, profitability, analyst recommendations, earnings, institutional ownership and dividends. Institutional and Insider Ownership 66.4% of Alphatec shares are owned
Alphatec Touts Share Gains, Valence Robot and Improving Cash Flow at Conference (NASDAQ:ATEC)
Executives from Alphatec (NASDAQ: ATEC) outlined their view of the spine surgery market, growth drivers, and recent financial progress during a conference discussion featuring Chief Financial Officer Todd Koning and Vice President of Finance and Head of Investor Relations Robert Judd. The conversation touched on investor questions about whether the company can sustain its growth rates
Alphatec Holdings, Inc. (ATEC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Alphatec Holdings, Inc. (ATEC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Alphatec Holdings: Buy On Solid Results And Outlook
Over the course of 2025, Alphatec Holdings or "ATEC" has continued to outperform sales expectations and taken additional share in the $8 billion U.S. spinal disorder treatment market. In addition, the company has delivered vastly improved profitability and cash flow. While moderately lower growth expectations for 2026 appear to have impacted the stock price in recent weeks, I would consider the selloff a buying opportunity.
